MRNA is S&P 500's top performing stock, here are the best Quant pharma companies [Seeking Alpha]
Indivior PLC (INDV)
Company Research
Source: Seeking Alpha
Moderna ( MRNA ) emerged as the top-performing pharmaceutical stock in the S&P 500 ( SP500 ) on Wednesday after announcing that its mRNA-based Newsletters for Every Investor Get daily, sector-specific newsletters packed with expert insights, fresh ideas, and new opportunities. Subscribe to Newsletters Sign Up Quick Insights The pharmaceutical sector continues to attract investor attention with notable clinical innovation and differentiated stock performance. Quant Ratings identify Indivior, Liquidia, and Sol-Gel as the highest-rated pharmaceutical stocks, all rated Strong Buy, with others like Pfizer and Merck also topping the list. Despite recent positive trial results and outperformance, Moderna is not among the top 15 due to Quant metrics, which consider multiple forward-looking performance factors. Recommended For You More Trending News
Show less
Read more
Impact Snapshot
Event Time:
INDV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
INDV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
INDV alerts
High impacting Indivior PLC news events
Weekly update
A roundup of the hottest topics
INDV
News
- Indivior (INDV) was upgraded by Zacks Research from "hold" to "strong-buy".MarketBeat
- Indivior (INDV) was downgraded by <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from "buy (b-)" to "hold (c+)".MarketBeat
- National Survey Finds Only 58% of U.S. Correctional Facilities Offer Medications for Opioid Use Disorder [Yahoo! Finance]Yahoo! Finance
- National Survey Finds Only 58% of U.S. Correctional Facilities Offer Medications for Opioid Use DisorderGlobeNewswire
- How Indivior's Upsized $450 Million Convertible Notes and Buybacks May Impact Indivior (INDV) Investors [Yahoo! Finance]Yahoo! Finance
INDV
Earnings
- 2/26/26 - Beat
INDV
Analyst Actions
- 1/12/26 - HC Wainwright
INDV
Sec Filings
- 3/23/26 - Form SCHEDULE
- 3/17/26 - Form 4
- 3/17/26 - Form 8-K
- INDV's page on the SEC website